2-Methylthio-ATP

From WikiMD's Wellness Encyclopedia


2-Methylthio-ATP (2-MeSATP) is a synthetic analogue of adenosine triphosphate (ATP) that is used in biochemical research to study the function of purinergic receptors, particularly the P2Y and P2X receptor subtypes. It is characterized by the substitution of a methylthio group at the 2-position of the adenine ring, which confers unique properties that make it useful for probing the physiological roles of ATP in cellular signaling.

Chemical Structure and Properties[edit | edit source]

2-Methylthio-ATP is a modified nucleotide with the chemical formula C11H18N5O13P3S. The presence of the methylthio group at the 2-position of the adenine base distinguishes it from natural ATP. This modification affects its interaction with purinergic receptors, making it a selective agonist for certain receptor subtypes.

Biological Activity[edit | edit source]

2-Methylthio-ATP is primarily used as a tool to study the activation of P2Y receptors, a class of G protein-coupled receptors that respond to extracellular nucleotides. It is known to activate P2Y1, P2Y2, and P2Y11 receptors, among others. Additionally, it can interact with certain P2X receptors, which are ligand-gated ion channels.

P2Y Receptor Activation[edit | edit source]

The activation of P2Y receptors by 2-MeSATP leads to various intracellular signaling cascades, including the activation of phospholipase C, which results in the production of inositol trisphosphate (IP3) and diacylglycerol (DAG). These second messengers play critical roles in calcium mobilization and protein kinase C activation, respectively.

P2X Receptor Interaction[edit | edit source]

While 2-MeSATP is less potent at P2X receptors compared to ATP, it can still serve as a partial agonist for certain subtypes, such as P2X1 and P2X3. This interaction is useful for dissecting the roles of these receptors in physiological and pathological processes.

Applications in Research[edit | edit source]

2-Methylthio-ATP is widely used in pharmacological studies to:

  • Characterize the pharmacodynamics of purinergic receptors.
  • Investigate the physiological roles of ATP in neurotransmission, inflammation, and other cellular processes.
  • Develop selective receptor agonists and antagonists for therapeutic purposes.

Safety and Handling[edit | edit source]

As with many biochemical reagents, 2-MeSATP should be handled with care. It is important to follow appropriate safety protocols, including the use of personal protective equipment and proper storage conditions, to ensure safe handling and disposal.

Also see[edit | edit source]

Template:Receptor pharmacology Template:Nucleotides

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD